-
www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary52/vitamin-d-and-calcium-to-prevent-fractures-preventive-medication-2013
December 10, 2011 - (RCTs) of generally healthy adults (<20% of study participants had major chronic diseases, such as diabetes … Effects of postmenopausal hormone replacement therapy with and without vitamin D3 on circulating levels … The effect of different vitamin D treatments on serum vitamin D levels in early postmenopausal women. … groups; 2 women were randomly assigned to the control group for every 1 woman randomly assigned to the treatment
-
hcup-us.ahrq.gov/reports/ataglance/HCUPanalysisHospUtilPregnancy.pdf
December 14, 2021 - quality of health services, medical practice patterns,
access to healthcare programs, and outcomes of treatments … condition, but either a secondary diagnosis
indicates a maternal condition, or a procedure code indicates treatment … organs
PRG018 Maternal care related to disorders of the placenta and placental implantation
PRG019 Diabetes … Diagnostic amniocentesis
139 Fetal monitoring
140 Repair of current obstetric laceration
141 Other therapeutic
-
www.ahrq.gov/sites/default/files/wysiwyg/professionals/quality-patient-safety/patient-safety-resources/resources/advances-in-patient-safety/vol1/Masheter.pdf
March 01, 2004 - People who would
have died or been bedridden by cancer, diabetes, heart disease, or other diseases … patient or group of patients would
provide useful information about whether a particular program of treatment … New medical
treatments, medications, and devices may expose patients to new health care-
related risks
-
hcup-us.ahrq.gov/db/nation/nis/NIS_Introduction_2014.jsp
January 01, 2014 - The NIS' large sample size enables analyses of rare conditions, uncommon treatments, and special patient … The new NIS retains a large sample size, which enables analyses of rare conditions, uncommon treatments … (0) Comorbidity is not present, (1) Comorbidity is present
CM_DM
AHRQ comorbidity measure: Diabetes … Comorbidity is not present, (1) Comorbidity is present
CM_DMCX
AHRQ comorbidity measure: Diabetes … , (3) Major Diagnostic, (4) Major Therapeutic
Linkage Data Elements
HOSP_NIS
NIS hospital
-
hcup-us.ahrq.gov/db/nation/nis/reports/2002niscomparisonrpt.jsp
June 01, 2016 - The estimated NIS rate was nearly twice as high for "physical therapy." … The relationship between hospital size and treatment patterns is an example. … disease
469 (10)
458 (22)
4.19 (0.03)
4.17 (0.31)
0.85 (0.03)
0.97 (0.06)
50: Diabetes … 1.55
4.93 (0.04)
5.03*
4.61 (0.11)
4.68
$17,380 (496)
$16,969
50: Diabetes … 1.41
5.45 (0.06)
5.39
4.19 (0.13)
3.97
$18,518 (640)
$17,818
146: Treatment
-
www.ahrq.gov/sites/default/files/wysiwyg/professionals/quality-patient-safety/patient-safety-resources/resources/advances-in-patient-safety-2/vol1/Advances-Quan_52.pdf
March 10, 2008 - could be used to explore
quality differences across 23 participating countries: (1) cardiac care, (2) diabetes … diagnostic
and monitoring devices
Y70.1 Anesthesiology devices associated with adverse incidents, therapeutic … Defining surgical discharges
requires identification of major therapeutic operations. … secondary diagnosis refers in Canada to a condition for which a patient may or may not have
received treatment
-
digital.ahrq.gov/sites/default/files/docs/Event%20Transcipt%20August.pdf
August 27, 2009 - policies,
as well as appropriate use of prescription drug and the complications that can ensue from drug
therapy … Therapeutic substitution here refers for example the use of inexpensive
generic and effective medications … medication with a lower co-payment, especially for drugs for
conditions like high blood pressure, diabetes … comes out, for example, and they want to let all of their patients know you can get
to a less-costly treatment … Does the introduction of this technology potentially mean we will
see a different way that medication therapy
-
digital.ahrq.gov/sites/default/files/docs/page/SureScripts%20Final%20Report.pdf
January 11, 2007 - Medication Therapy Intervention(MTI): A Medication Therapy Intervention (MTI) documentation form was … The choice of treatment gaps is variable. … compliance including monitoring the use of controlled
substances and managing chronic conditions such as diabetes … With new prescriptions, a change might require re-negotiation and re-education of patients about a treatment … side effect, or whether previous therapies have been effective.
-
hcup-us.ahrq.gov/db/nation/nis/NIS_Introduction_2013.jsp
January 01, 2013 - The NIS' large sample size enables analyses of rare conditions, uncommon treatments, and special patient … The new NIS retains a large sample size, which enables analyses of rare conditions, uncommon treatments … (0) Comorbidity is not present, (1) Comorbidity is present
CM_DM
AHRQ comorbidity measure: Diabetes … , (3) Major Diagnostic, (4) Major Therapeutic
Linkage Data Elements
HOSP_NIS
NIS hospital … LTAC hospitals typically provide comprehensive rehabilitation, respiratory therapy, head trauma treatment
-
www.ahrq.gov/sites/default/files/wysiwyg/nursing-home/materials/covid19-vaccine-confidence-curriculum-learning-guide-staff.pdf
March 01, 2021 - vaccines.2
• If you have a history of severe allergic reaction to any other vaccine or injectable therapy … • Chronic diseases like high blood pressure, diabetes, heart disease, asthma, other chronic respiratory … This can make it harder
to control chronic diseases, be tested for COVID-19, and obtain treatment.
-
hcup-us.ahrq.gov/datainnovations/clinicalcontentenhancementtoolkit/hi6.jsp
July 07, 2016 - %|4.0-6.0|L|||F|||200905041232|C^LAB IT|
OBX|1|TX|HA1C^Hemoglobin A1C|2|Note: Values <7% meet the treatment … goal for patients with
diabetes|||||||||200905041232|C^LAB IT|
OBX|1|TX|HA1C^Hemoglobin A1C|3| mellitus
-
digital.ahrq.gov/sites/default/files/docs/page/guide-to-evaluating-hie-projects-section-4.pdf
June 16, 2021 - randomized controlled trial, subjects are randomly assigned to receive the
intervention or control treatment
-
digital.ahrq.gov/sites/default/files/docs/publication/uc1hs014882-ferranti-final-report-2008.pdf
January 01, 2008 - Department of Health and Human Services of a particular drug, device, test, treatment, or
other clinical … patient per severity score AND Naranjo causality score of Probable or
Definite ADE); and number of therapeutic … Using Information Technology to Detect
Ambulatory Adverse Events Related to Anti-diabetic Drug
Therapy
-
hcup-us.ahrq.gov/db/nation/kid/kid_2006_introduction.jsp
January 01, 2006 - KID's large sample size enables analyses of rare conditions, such as congenital anomalies and uncommon treatments … , 2006
AHRQ comorbidity measure: Depression
CM_DM
2003, 2006
AHRQ comorbidity measure: Diabetes … , uncomplicated
CM_DMCX
2003, 2006
AHRQ comorbidity measure: Diabetes with chronic complications … , (3) Major Diagnostic, (4) Major Therapeutic
Linkage Variables
HOSPID
2006
HCUP hospital … data), long-term non-acute care hospitals, psychiatric hospitals, and alcoholism/chemical dependency treatment
-
www.ahrq.gov/research/findings/final-reports/ssi/ssi3.html
April 01, 2018 - preoperative risk factor, this finding was indicative of the need for hospitalization for postoperative wound treatment
-
www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary-supplemental-screening-in-women-with-dense-/breast-cancer-screening-january-2016
January 11, 2016 - Increased breast density has been associated with hormone replacement therapy use, younger age, and lower … creatinine before administration of gadolinium for those aged 60 years and older with hypertension, diabetes … addressed
the important potential risks of overdiagnosis
and the associated harms of unnecessary treatment … Assessment of mammographic density in postmenopausal women during long term hormone replacement therapy … <36 mo
Women aged 40 years and older, with no history of breast cancer or reported use of hormone therapy
-
hcup-us.ahrq.gov/reports/methods/2005_03_del_379.pdf
January 01, 2005 - The
estimated NIS rate was nearly twice as high for “physical therapy.” … The relationship between hospital size and
treatment patterns is an example. … Biliary tract disease 469
(10)
458
(22)
4.19
(0.03)
4.17
(0.31)
0.85
(0.03)
0.97
(0.06)
50: Diabetes … 217
(4)
179** 1.57
(0.01)
1.55 4.93
(0.04)
5.03* 4.61
(0.11)
4.68 $17,380
(496)
$16,969
50: Diabetes … 186
(6)
163** 1.34
(0.04)
1.41 5.45
(0.06)
5.39 4.19
(0.13)
3.97 $18,518
(640)
$17,818
146: Treatment
-
digital.ahrq.gov/sites/default/files/docs/citation/r21hs026505-wallace-final-report-2020.pdf
January 01, 2020 - of its impact on patients and access to resources, including ethical
concerns such as compromising therapeutic … populations (e.g. those without insurance) unfavorably, and such efforts are even likely to
undermine therapeutic … Integrating Social Determinants
of Health With Treatment and Prevention: A New Tool to Assess Local … Using RE-AIM metrics to evaluate
diabetes self-management support interventions.
-
hcup-us.ahrq.gov/datainnovations/clinicaldata/3MSummaryResultsReportFinal.jsp
October 03, 2010 - Some of the exempt V codes provide information about the circumstances of treatment such as no proc/contraindicated … For example, chronic conditions that could not have arisen after hospital admission such as diabetes, … Induced Organic Mental Disorders
Poisonings, Toxic Effects, Other Injuries and Other Complications of Treatment
-
hcup-us.ahrq.gov/datainnovations/clinicalcontentenhancementtoolkit/hi25.pdf
October 01, 2011 - |%|4.0-6.0|L|||F|||200905041232|C^LAB IT|
OBX|1|TX|HA1C^Hemoglobin A1C|2|Note: Values <7% meet the treatment … goal for patients
with
diabetes|||||||||200905041232|C^LAB IT|
OBX|1|TX|HA1C^Hemoglobin A1C|3| mellitus … The medical record number is typically used to do an audit of
the history of treatment.